Skip to main content

Advertisement

SpringerLink
Log in

Melanoma in relation to reproductive and hormonal factors in women: current review on controversial issues

  • Review Article
  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

Purpose

About one third of all melanoma in women occur during their childbearing age. An association between melanoma and hormonal and reproductive factors remains controversial.

Methods

This article reviews current evidence on the link between melanoma and reproductive factors. A comprehensive search of Medline (from 1966 to July 2007) and Embase (1974 to July 2007) was performed. Articles were reviewed and additional references were obtained from the bibliographies.

Results

Several controversial issues have been discussed. A pooled analysis of 10 case–control studies including a total of 5,590 women found a lack of association between melanoma risk and pregnancy. Data suggested that women with higher parity (five or more live births) had moderately lower melanoma risk compared with nulliparous women. Current evidence demonstrated that pregnancy did not appear to affect survival in women with melanoma. Based on the current evidence there is no reason to recommend deferral of subsequent pregnancy in women in whom a primary melanoma is diagnosed during pregnancy. The data revealed no relation between melanoma risk and use of oral contraceptives and hormone replacement therapy (HRT).

Conclusion

Exogenous or endogenous female hormones do not contribute significantly to increased risk of melanoma. Melanoma prognosis does not appear to be affected by pregnancy. Termination of pregnancy in women diagnosed with a primary melanoma during pregnancy is not recommended. There is no evidence to support deferral of pregnancy in women with melanoma history except that at the end of 2 years patients have a better estimate of their risk of recurrence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Marks R (2000) Epidemiology of melanoma. Clin Exp Dermatol 25:459–463

    Article  PubMed  CAS  Google Scholar 

  2. Lens MB, Dawes M (2004) Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol 150(2):179–185

    Article  PubMed  CAS  Google Scholar 

  3. Whiteman DC, Stickley M, Watt P, Hughes MC, Davis MB, Green AC (2006) Anatomic site, sun exposure, and risk of cutaneous melanoma. J Clin Oncol 24(19):3172–3177

    Article  PubMed  Google Scholar 

  4. Colbourn DS, Nathanson L, Belilos E (1989) Pregnancy and melanoma. Semin Oncol 16:377–387

    PubMed  CAS  Google Scholar 

  5. Potter JF, Schoeneman M (1970) Metastasis of maternal cancer to the placenta and fetus. Cancer 25:380–387

    Article  PubMed  CAS  Google Scholar 

  6. Matthiasen L, Berg G (1989) Malignant melanoma, the most common cancer type, first appearing during pregnancy. Läkartidningen 86:2845–2848

    Google Scholar 

  7. Garbe C (1993) Pregnancy, hormone preparations and malignant melanoma. Hautarzt 44:347–352

    PubMed  CAS  Google Scholar 

  8. Smith RS, Randall P (1969) Melanoma during pregnancy. Obstet Gynecol 34:825–829

    PubMed  CAS  Google Scholar 

  9. Dillman RO, Vandermolen LA, Barth NM, Bransford KJ (1996) Malignant melanoma and pregnancy. West J Med 164:156–161

    PubMed  CAS  Google Scholar 

  10. Lens MB, Rosdahl I, Ahlbom A, Farahmand BY, Synnerstad I, Boeryd B et al (2004) Effect of pregnancy on survival in women with cutaneous malignant melanoma. J Clin Oncol 22(21):4369–4375

    Article  PubMed  Google Scholar 

  11. Ariel IM (1980) Theories regarding the cause of malignant melanoma. Surg Gynecol Obstet 150:907–917

    PubMed  CAS  Google Scholar 

  12. Karagas MR, Zens MS, Stukel TA, Swerdlow AJ, Rosso S, Osterlind A et al (2006) Pregnancy history and incidence of melanoma in women: a pooled analysis. Cancer Causes Control 17(1):11–19

    Article  PubMed  Google Scholar 

  13. Kaae J, Andersen A, Boyd HA, Wohlfahrt J, Melbye M (2007) Reproductive history and cutaneous malignant melanoma: a comparison between women and men. Am J Epidemiol 165(11):1265–1270

    Article  PubMed  Google Scholar 

  14. Pack GT, Scharnagel IM (1951) Prognosis of malignant melanoma in pregnant women. Cancer 4:324–334

    Article  PubMed  CAS  Google Scholar 

  15. Sutherland CM, Loutfi A, Mather FJ, Carter RD, Krementz ET (1983) Effect of pregnancy upon malignant melanoma. Surg Gynecol Obstet 157:443–446

    PubMed  CAS  Google Scholar 

  16. Trapeznikov NN, Khasanov SR, Iavorskii VV (1987) Melanoma of the skin and pregnancy. Voproxy Onkologii 33:40–46

    CAS  Google Scholar 

  17. Byrd BF, McGanty WJ (1954) Effect of pregnancy on clinical course of melanoma. Southeastern Med J 47:196–200

    Google Scholar 

  18. Holly EA (1986) Melanoma and pregnancy. Recent Results Cancer Res 102:118–126

    PubMed  CAS  Google Scholar 

  19. Houghton AM, Flannery J, Viola MV (1981) Malignant melanoma of the skin occurring during pregnancy. Cancer 48:407–410

    Article  PubMed  CAS  Google Scholar 

  20. Reintgen DS, McCarty KS Jr, Vollmer R, Cox E, Seigler HF (1985) Malignant melanoma and pregnancy. Cancer 55:1340–1344

    Article  PubMed  CAS  Google Scholar 

  21. McManamny DS, Moss ALH, Pocock PV, Briggs JC (1989) Melanoma and pregnancy: a long-term follow-up. Br J Obstet Gynaecol 96:1419–1423

    PubMed  CAS  Google Scholar 

  22. Wong JH, Sterns EE, Kopald KH, Nizze JA, Morton DL (1989) Prognostic significance of pregnancy in stage I melanoma. Arch Surg 124:1227–1231

    PubMed  CAS  Google Scholar 

  23. Slingluff CL Jr, Reintgen DS, Volmer RT, Seigler HF (1990) Malignant melanoma arising during pregnancy—a study of 100 patients. Ann Surg 211:552–559

    Article  PubMed  Google Scholar 

  24. MacKie RM, Bufalino R, Morabito A, Sutherland C, Cascinelli N (1991) Lack of effect of pregnancy on outcome of melanoma—the World Health Organisation melanoma programme. Lancet 337:653–655

    Article  PubMed  CAS  Google Scholar 

  25. O’Meara AT, Cress R, Xing G, Danielsen B, Smith LH (2005) Malignant melanoma in pregnancy. A population-based evaluation. Cancer 103(6):1217–1226

    Article  PubMed  Google Scholar 

  26. Martin AG, Leal-Khouri S (1992) Physiologic skin changes associated with pregnancy. Int J Dermatol 31:375–378

    Article  PubMed  CAS  Google Scholar 

  27. Pennoyer JW, Grin CM, Driscoll MS, Dry SM, Walsh SJ, Gelineau JP et al (1997) Changes in size of melanocytic nevi during pregnancy. J Am Acad Dermatol 36(3 Pt 1):378–382

    Article  PubMed  CAS  Google Scholar 

  28. Travers RL, Sober AJ, Berwick M, Mihm MC Jr, Barnhill RL, Duncan LM (1995) Increased thickness of pregnancy-associated melanoma. Br J Dermatol 132(6):876–883

    Article  PubMed  CAS  Google Scholar 

  29. Resnick R (1999) Cancer during pregnancy. N Engl J Med 341:120–121

    Article  Google Scholar 

  30. Leslie KK, Espey E (2005) Oral contraceptives and skin cancer: is there a link? Am J Clin Dermatol 6(6):349–355

    Article  PubMed  Google Scholar 

  31. Feskanich D, Hunter DJ, Willett WC, Spiegelman D, Stampfer MJ, Speizer FE et al (1999) Oral contraceptive use and risk of melanoma in premenopausal women. Br J Cancer 81(5):918–923

    Article  PubMed  CAS  Google Scholar 

  32. Pfahlberg A, Hassan K, Wille L, Lausen B, Gefeller O (1997) Systematic review of case–control studies: oral contraceptives show no effect on melanoma risk. Public Health Rev 25:309–315

    PubMed  CAS  Google Scholar 

  33. Karagas MR, Stukel TA, Dykes J, Miglionico J, Greene MA, Carey M et al (2002) A pooled analysis of 10 case–control studies of melanoma and oral contraceptive use. Br J Cancer 86(7):1085–1092

    Article  PubMed  CAS  Google Scholar 

  34. Durvasula R, Ahmed SM, Vashisht A, Studd JW (2002) Hormone replacement therapy and malignant melanoma: to prescribe or not to prescribe? Climacteric 5(2):197–200

    Article  PubMed  CAS  Google Scholar 

  35. Grin CM, Driscoll MS, Grant-Kels JM (1998) The relationship of pregnancy, hormones, and melanoma. Semin Cutan Med Surg 17(3):167–171

    Article  PubMed  CAS  Google Scholar 

  36. Baergen RN, Johnson D, Moore T et al (1997) Maternal melanoma metastatic to the placenta: a case report and review of the literature. Arch Pathol Lab Med 121:508–511

    PubMed  CAS  Google Scholar 

  37. Alexander A, Samlowski WE, Grossman D, Bruggers CS, Harris RM, Zone JJ et al (2003) Metastatic melanoma in pregnancy: risk of transplacental metastases in the infant. J Clin Oncol 21(11):2179–2186

    Article  Google Scholar 

  38. Anderson JF, Kent S, Machin GA (1989) Maternal malignant melanoma with placental metastasis: a case report with literature review. Pediatr Pathol 9:35–42

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Twin Research and Genetic Epidemiology Unit, King’s College London, St. Thomas’ Hospital Campus, Lambeth Palace Road, London, SE1 7EH, UK

    Marko Lens

  2. Dermatology Department, West Herts NHS Trust, Hemel Hempstead, Hertfordshire, UK

    Veronique Bataille

Authors
  1. Marko Lens
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Veronique Bataille
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marko Lens.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lens, M., Bataille, V. Melanoma in relation to reproductive and hormonal factors in women: current review on controversial issues. Cancer Causes Control 19, 437–442 (2008). https://doi.org/10.1007/s10552-008-9110-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10552-008-9110-4

Keywords

Search

Navigation